All Stories

  1. Two decades and beyond: What we know and still need to learn about the TWEAK/Fn14 pathway
  2. Proteotoxicity and tubular epithelial cell fate in acute kidney injury: Molecular insights and treatment strategies
  3. Plant-derived essential oils in lung cancer: Anticancer mechanisms, experimental progress, and future perspectives
  4. Targeting BMP2 signaling pathway in osteogenesis and osteoarthritis: A path toward safer regenerative therapies
  5. QbD-designed development and evaluation of bexarotene-loaded Cubosome gel for enhanced skin permeation in psoriasis treatment
  6. ROS-responsive drug delivery systems: Harnessing redox biology for targeted therapies
  7. Unveiling the Power of Deuterium in Drug Discovery: A Comprehensive Overview
  8. Medicinal Insights Into FLT3 Inhibitors as Anticancer Agents: Current Status and Future Direction
  9. Quercetin nanoemulsion ameliorates key hallmarks of lung cancer
  10. Biomaterial-enables targeted drug delivery for obesity: Adipose-targeted nanocarriers and tissue-specific therapies
  11. Molecular modelling–driven formulation design for targeted pulmonary drug delivery
  12. Bioorganic design of metal–organic frameworks for targeted and stimuli-responsive anticancer drug delivery
  13. Innovative methodologies for elucidating bushfire smoke-induced pathophysiological mechanism
  14. Arc-discharge synthesis of potent calcium-decorated MWCNTs as potential coating nanomaterials for orthopedic implants
  15. 18-β-Glycyrrhetinic-loaded poly(lactic-co-glycolic) (PLGA) nanoparticles downregulate the expression LPS-induced proteins mediating tissue remodelling in vitro
  16. Concentration-Dependent Impact of Polystyrene Nanoplastic on Lung Surfactant Monolayer in Alveolar Fluid: A Molecular Dynamics Study
  17. Nanotechnology-based advancements in Parkinson's therapy: Exploring animal models and clinical insights in neurodegenerative disorders
  18. Comparative review of the pharmacokinetics and pharmacodynamics of testosterone therapies in type 2 diabetes
  19. Evolving paradigms in targeting FLT3 for acute myeloid leukemia therapy
  20. Novel eugenol/limonene nanoplatform as a new remedy against bacterial lung infections
  21. Investigating the therapeutic potential of polymeric roflumilast nanosuspension in modulating asthma hallmarks using an in vivo ovalbumin model
  22. Preparation, Characterization and In-Vitro Efficacy of Roflumilast Nanosuspension in Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease
  23. Novel Therapeutic Approaches to Metabolic Syndrome
  24. Revolutionizing cancer treatment: Nanotherapeutics targeting the tumor micro-environment
  25. Chitosan-based systems for advanced wound healing
  26. Computational analysis of human metapneumovirus particle behaviour in the pulmonary system
  27. Myeloperoxidase as a Biomarker in COPD
  28. The gut microbiome of Australian cats and dogs: Dietary influences, health impacts, and emerging research
  29. Emerging Trends and Advances in Antioxidant-Based Plant Derived Nano Formulations in Alleviating Lung Diseases
  30. Nanostructured lipid nanoparticles delivering berberine with Se coating: a new nanotherapeutic approach against cryptosporidiosis
  31. Fisetin-loaded Nanoemulsion and Fecal Microbiome Extract Enhance In Vitro Inhibition of Non-Small Cell Lung Cancer Progression
  32. Eco-Friendly Combat against Prostate Cancer: Green Chemistry Approach Using Biosynthesized Nanoparticles Functionalized with Propolis for Enhanced Anticancer Activity
  33. Contamination of Polycyclic Aromatic Hydrocarbons in Foods and the Food Chain
  34. Exploring the Therapeutic Potential of Nobiletin in Nonsmall Cell Lung Cancer
  35. Healthy Ageing in Nepal: Key Challenges and Possible Solutions
  36. Concept and Therapeutic Applications: The Endocrine Pancreas
  37. Ferroptosis and iron homeostasis in chronic obstructive pulmonary disease: Therapeutic opportunities of iron chelators
  38. Fluorescent metal nanoclusters for food safety: Advances, challenges, and future perspectives in contaminant detection
  39. Inhaled Microplastics and Lung Health: Immunopathological Effects and Disease Implications
  40. Do microplastics play a role in the pathogenesis of neurodegenerative diseases? Shared pathophysiological pathways for Alzheimer’s and Parkinson’s disease
  41. Current Landscape of Novel Therapeutic Agents and Drug Targets in Irritable Bowel Syndrome
  42. Box–Behnken-designed nanostructured lipid carriers of xanthohumol for enhanced cellular uptake in human lung cancer cell line A549: formulation, optimization, characterization, and cytotoxicity assessment
  43. Investigating the Therapeutic Potential of Agarwood Nanoemulsion in Modulating TGF-β-Induced Airway Remodelling in BEAS-2B Cells
  44. Liposomal drug delivery system for lung diseases: Recent advancement and future perspectives
  45. Cigarette smoke exposure differentially affects male and female steroid hormone production and lung function in a COPD mouse model
  46. One-step synthesis of TiO2@MWCNT by plasma reactor for wastewater purification
  47. Comparative assessment of antibiofilm and antioxidant activities between curcuma longa silver nano particles and ethanolic extract of curcuma longa
  48. Cost-effective synthesis of magnesium hydroxide and magnesium oxide by arc discharge method: Comparative studies for their biological activities
  49. Cellular senescence in chronic obstructive pulmonary disease: Molecular mechanisms and therapeutic interventions
  50. Functional crosstalk between the lung and eye: a new frontier in chronic lung diseases
  51. Exploring Protein Aggregation in Biological Products: From Mechanistic Understanding to Practical Solutions
  52. Algal bioactives: Unlocking future frontiers in respiratory therapeutics
  53. Exosomal delivery of non-coding RNAs: a pathway to apoptosis regulation in lung cancer
  54. Targeting oncogenic signaling pathways in lung Cancer: The emerging role of nobiletin, a flavonoid from citrus peel
  55. Advances in Alzheimer's therapy: Exploring neuropathological mechanisms to revolutionize the future therapeutic landscape
  56. Unravelling the role of nanomedicine in attenuating inflammation, oxidative stress and cellular ageing in chronic obstructive pulmonary disease
  57. Exploring natural components in vaccine delivery systems: Types, routes of administration, in-vitro and in-vivo quantification techniques
  58. From nature to nanotech: Unlocking Berberine's therapeutic approaches
  59. Application of Self-Nanoemulsifying Drug Delivery Systems in Inflammatory Diseases
  60. Investigating the Harmful Effects of Bushfire Smoke Exposure in Precision Cut Lung Slices
  61. Predicting Motif-Mediated Interactions Based on Viral Genomic Composition
  62. Central composite designed boswellic acids loaded nanoparticles for enhanced cellular uptake in human lung cancer cell line A549
  63. Bridging gap in the treatment of Alzheimer’s disease via postbiotics: Current practices and future prospects
  64. Does drug repurposing bridge the gaps in management of Parkinson’s disease? Unravelling the facts and fallacies
  65. A Critical Review on the Long-Term COVID-19 Impacts on Patients With Diabetes
  66. Potent phytoceuticals cocktail exhibits anti-inflammatory and antioxidant activity on LPS-triggered RAW264.7 macrophages in vitro
  67. Antioxidants, Radical Scavengers, and Their Impact on Oxidative Stress
  68. From Antipsychotic to Neuroprotective: Computational Repurposing of Fluspirilene as a Potential PDE5 Inhibitor for Alzheimer's Disease
  69. Multifunctional Plumeria rubra nanoparticles: Antimicrobial, antiviral, antiparasitic and anti-inflammatory activities
  70. Nanotechnology-Driven Treatment Strategies for Breast Cancer: Recent Advances and Innovations
  71. Interplay of nano-based delivery systems and protein signalling in ameliorating lung diseases
  72. The impact of airborne particulate matter-based pollution on the cellular and molecular mechanisms in chronic obstructive pulmonary disease (COPD)
  73. Non-coding RNA: A key regulator in the Glutathione-GPX4 pathway of ferroptosis
  74. Recent trends and therapeutic potential of phytoceutical‐based nanoparticle delivery systems in mitigating non‐small cell lung cancer
  75. Influence of gut and lung dysbiosis on lung cancer progression and their modulation as promising therapeutic targets: a comprehensive review
  76. Bridging gap in treatment of polycystic ovarian syndrome through drug repurposing: what we achieved and where we are?
  77. Cellular probing using phytoceuticals encapsulated advanced delivery systems in ameliorating lung diseases: Current trends and future prospects
  78. Unlocking the future of osteoarthritis: Material engineering and drug delivery confluence for advanced therapeutic approaches
  79. Therapeutic potential of 18-β-glycyrrhetinic acid-loaded poly (lactic-co-glycolic acid) nanoparticles on cigarette smoke-induced in-vitro model of COPD
  80. Revolutionizing Eye Care: Exploring the Potential of Microneedle Drug Delivery
  81. Exploring nanoparticular platform in delivery of repurposed drug for Alzheimer’s disease: current approaches and future perspectives
  82. Exploring Bioactive Phytomedicines for Advancing Pulmonary Infection Management: Insights and Future Prospects
  83. Advancing against drug-resistant tuberculosis: an extensive review, novel strategies and patent landscape
  84. The antiparasitic effect of C-Phycocyanin nanoparticles on cryptosporidiosis in immunosuppressed mice
  85. Liposomal encapsulated curcumin attenuates lung cancer proliferation, migration, and induces apoptosis
  86. Chungtaejeon (CTJ) inhibits adhesion and migration of VSMC through cytoskeletal remodeling pathway
  87. Computational and biological approaches in repurposing ribavirin for lung cancer treatment: Unveiling antitumorigenic strategies
  88. Innovative phytoceutical-based drug delivery in the management of pulmonary fibrosis: A roadmap towards inhaled therapeutics
  89. Application of quality by design in optimization of nanoformulations: Principle, perspectives and practices
  90. Liposomal curcumin inhibits cigarette smoke induced senescence and inflammation in human bronchial epithelial cells
  91. Fecal microbiome extract downregulates the expression of key proteins at the interface between airway remodelling and lung cancer pathogenesis in vitro
  92. Neurodegenerative disorders: Mechanisms of degeneration and therapeutic approaches with their clinical relevance
  93. Mesenchymal stem cell membrane-coated nanoconstructs: why have they not yet found a home in clinical practice?
  94. Effectiveness of phytoconstituents and potential of phyto-nanomedicines combination to treat osteoarthritis
  95. Exploring the role of the ocular surface in the lung-eye axis: Insights into respiratory disease pathogenesis
  96. ncRNAs and their impact on dopaminergic neurons: Autophagy pathways in Parkinson's disease
  97. Revolutionizing Eye Care: Exploring the Potential of Microneedle Drug Delivery
  98. Cellular senescence in lung cancer: Molecular mechanisms and therapeutic interventions
  99. Exploring the anti-inflammatory and anti-fibrotic activity of NFκB decoy oligodeoxynucleotide-loaded spermine-functionalized acetalated nanoparticles
  100. In silico design and evaluation of a multiepitope vaccine targeting the nucleoprotein of Puumala orthohantavirus
  101. Exploring the current advancements of quercetin nanoformulations alleviating respiratory diseases
  102. Revolutionizing lung health: Exploring the latest breakthroughs and future prospects of synbiotic nanostructures in lung diseases
  103. 18-β-Glycyrrhetinic acid encapsulated PLGA nanoparticles attenuate lung cancer proliferation and migration
  104. 18-β-glycyrrhetinic acid-loaded polymeric nanoparticles attenuate cigarette smoke-induced markers of impaired antiviral response in vitro
  105. Curcumin-loaded liposomes modulating the synergistic role of EpCAM and estrogen receptor alpha in lung cancer management
  106. The impact of formaldehyde exposure on lung inflammatory disorders: Insights into asthma, bronchitis, and pulmonary fibrosis
  107. Emerging role of tumor suppressing microRNAs as therapeutics in managing non-small cell lung cancer
  108. Plant-based therapeutics for chronic obstructive pulmonary diseases: Nanoformulation strategies to overcome delivery challenges
  109. Exploring Viral–Host Protein Interactions as Antiviral Therapies: A Computational Perspective
  110. RETRACTED ARTICLE: Polysaccharide-fecal microbiota-based colon-targeted self-nanoemulsifying drug delivery system of curcumin for treating polycystic ovarian syndrome
  111. Prediction of virus–host interactions and identification of hot spot residues of DENV-2 and SH3 domain interactions
  112. Uncovering domain motif interactions using high‐throughput protein–protein interaction detection methods
  113. TSANZ Abstracts
  114. Futuristic Senolytic Drug Incorporated Nanomedicine Therapy to Treat Osteoarthritis
  115. Opening avenues for treatment of neurodegenerative disease using post-biotics: Breakthroughs and bottlenecks in clinical translation
  116. Prediction of motif-mediated viral mimicry through the integration of host–pathogen interactions
  117. Docetaxel-loaded nanoformulations delivery for breast cancer management: Challenges, recent advances, and future perspectives
  118. The application of nanoparticles as advanced drug delivery systems in Attenuating COPD
  119. Proteome‐wide assessment of human interactome as a source of capturing domain–motif and domain‐domain interactions
  120. Immunotherapy Against Lung Cancer
  121. Antioxidant genes in cancer and metabolic diseases: Focusing on Nrf2, Sestrin, and heme oxygenase 1
  122. Knowledge on Chemical Pesticide use among Farmers Exposed to Pesticides in Panchkhal Municipality, Kavrepalanchok, Nepal
  123. Involvement of osteopontin, EpCAM, estrogen receptor-alpha, and carbonic anhydrase IX protein in managing lung cancer via Berberine-loaded liquid crystalline nanoparticles
  124. Liposomal Encapsulated Curcumin Attenuates Lung Cancer Proliferation, Migration and Apoptosis
  125. Ribavirin attenuates carcinogenesis by downregulating IL-6 and IL-8 in vitro in human lung adenocarcinoma
  126. Bioinformatics prediction and screening of viral mimicry candidates through integrating known and predicted DMI data
  127. Unraveling the role of glial cell line–derived neurotrophic factor in the treatment of Parkinson’s disease
  128. Dissecting the in vitro fate of plant-derived bioactive encapsulated nanoparticles in lung diseases
  129. Applications and advancements of nanoparticle-based drug delivery in alleviating lung cancer and chronic obstructive pulmonary disease
  130. Emerging applications and prospects of NFκB decoy oligodeoxynucleotides in managing respiratory diseases
  131. A Comprehensive review on Pharmacokinetic Studies of Vaccines: Impact of delivery route, carrier-and its modulation on immune response
  132. Agarwood oil nanoemulsion counteracts LPS-induced inflammation and oxidative stress in RAW264.7 mouse macrophages
  133. Inhalation drug delivery in combating pulmonary infections: Advances and challenges
  134. Zerumbone liquid crystalline nanoparticles protect against oxidative stress, inflammation and senescence induced by cigarette smoke extract in vitro
  135. Berberine-loaded engineered nanoparticles attenuate TGF-β-induced remodelling in human bronchial epithelial cells
  136. In vitro anti-cancer activity of a polyherbal preparation, VEDICINALS®9, against A549 human lung adenocarcinoma cells
  137. The potent synergistic effect of Brassica oleracea against congenital Toxoplasma infection in rat model
  138. Pre-clinical lung squamous cell carcinoma mouse models to identify novel biomarkers and therapeutic interventions
  139. An overview of biomedical applications for gold nanoparticles against lung cancer
  140. Front Cover Image, Volume 43, Issue 5
  141. Cigarette smoking induces lung cancer tumorigenesis via upregulation of the WNT/β-catenin signaling pathway
  142. Unravelling the role of solid lipid nanoparticles in drug delivery: Journey from laboratory to clinical trial
  143. Zerumbone-incorporated liquid crystalline nanoparticles inhibit proliferation and migration of non-small-cell lung cancer in vitro
  144. Antidiabetic evaluation of vanillic acid-glyburide loaded polymeric micelles in high fat diet and streptozotocin induced diabetic rats
  145. Berberine nanostructures attenuate ß-catenin, a key component of epithelial mesenchymal transition in lung adenocarcinoma
  146. Role of Flavonoids in Management of Various Biological Targets in Alzheimer’s Disease: Evidence from Preclinical to Clinical Studies
  147. Boswellic Acids: A Critical Appraisal of Their Therapeutic and Nutritional Benefits in Chronic Inflammatory Diseases
  148. Advanced models for respiratory disease and drug studies
  149. Exploring the Remarkable Chemotherapeutic Potential of Polyphenolic Antioxidants in Battling Various Forms of Cancer
  150. Progress in Understanding Metabolic Syndrome and Knowledge of Its Complex Pathophysiology
  151. Nanoformulations-Based Metronomic Chemotherapy: Mechanism, Challenges, Recent Advances, and Future Perspectives
  152. Anticancer activity of NFκB decoy oligonucleotide-loaded nanoparticles against human lung cancer
  153. Tackling the cytokine storm using advanced drug delivery in allergic airway disease
  154. Design and synthesis of novel bis-pyridinium based-ionic liquids as potent antiparasitic agents
  155. Progress on Understanding Metabolic Syndrome, and Knowledge of Its Complex Pathophysiology
  156. Agarwood Oil Nanoemulsion Attenuates Cigarette Smoke-Induced Inflammation and Oxidative Stress Markers in BCi-NS1.1 Airway Epithelial Cells
  157. The Pandemic and Your Skin—Direct and Indirect Impact of COVID-19
  158. Extracellular Vesicles Released from Cancer Cells Promote Tumorigenesis by Inducing Epithelial to Mesenchymal Transition via β-Catenin Signaling
  159. The significance of quercetin-loaded advanced nanoformulations for the management of diabetic wounds
  160. Targeting vascular inflammation in atherosclerosis with plant extracts, phytochemicals, and their advanced drug formulations
  161. Synbiotics for the Management of Cancer
  162. Editorial: Drug repurposing and polypharmacology: A synergistic approach in multi-target based drug discovery
  163. Bioactive Compounds from the Plants of the Elaeodendron Genus and Their Biological Activities—A Review
  164. Phytantriol-Based Berberine-Loaded Liquid Crystalline Nanoparticles Attenuate Inflammation and Oxidative Stress in Lipopolysaccharide-Induced RAW264.7 Macrophages
  165. Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases
  166. Prevalence and Factors Associated with Tobacco Use among High School Students
  167. Targeting the mitochondria in chronic respiratory diseases
  168. Vitamin D—A prominent immunomodulator to preventCOVID‐19 infection
  169. Anti-Influenza Virus Potential of Probiotic Strain Lactoplantibacillus plantarum YML015 Isolated from Korean Fermented Vegetable
  170. Nutraceuticals and COVID‐19: A mechanistic approach toward attenuating the disease complications
  171. The Emerging Role of Pericyte-Derived Extracellular Vesicles in Vascular and Neurological Health
  172. Advancements in nanotherapeutics targeting senescence in chronic obstructive pulmonary disease
  173. Formulation and Development of Adapalene Topical Nanohydrogel Using Different Surfactants and Cosurfactants for Antiacne Activity: In Vitro and Ex Vivo Evaluation
  174. Unravelling the Therapeutic Potential of Nano-Delivered Functional Foods in Chronic Respiratory Diseases
  175. Recent developments, challenges and future prospects in advanced drug delivery systems in the management of tuberculosis
  176. Advances in research with rutin-loaded nanoformulations in mitigating lung diseases
  177. Recent advances in lung-on-a-chip models
  178. Targeting mucus barrier in respiratory diseases by chemically modified advanced delivery systems
  179. Stinging Nettle (Urtica dioica L.): Nutritional Composition, Bioactive Compounds, and Food Functional Properties
  180. Editorial: Advanced therapeutic delivery for the management of chronic respiratory diseases
  181. Polymeric micelles loaded with glyburide and vanillic acid: I. Formulation development, in-vitro characterization and bioavailability studies
  182. Advances and applications of dextran-based nanomaterials targeting inflammatory respiratory diseases
  183. Topical non-aqueous nanoemulsion of Alpinia galanga extract for effective treatment in psoriasis: In vitro and in vivo evaluation
  184. Nutraceuticals and mitochondrial oxidative stress: bridging the gap in the management of bronchial asthma
  185. A kNGR Peptide-Tethered Lipid–Polymer Hybrid Nanocarrier-Based Synergistic Approach for Effective Tumor Therapy: Development, Characterization, Ex-Vivo, and In-Vivo Assessment
  186. Adverse roles of mast cell chymase-1 in chronic obstructive pulmonary disease
  187. Role of oxidative stress in the pathogenesis of COPD
  188. Editorial: Pharmacology of Plant Polyphenols in Human Health and Diseases
  189. Autoantibodies and autoimmune disorders in SARS-CoV-2 infection: pathogenicity and immune regulation
  190. Journey of Alpinia galanga from kitchen spice to nutraceutical to folk medicine to nanomedicine
  191. Biomedical applications of metallic nanoparticles in cancer: Current status and future perspectives
  192. “Nanodecoys” - Future of drug delivery by encapsulating nanoparticles in natural cell membranes
  193. Evaluation of the Cytotoxic Activity and Anti-Migratory Effect of Berberine–Phytantriol Liquid Crystalline Nanoparticle Formulation on Non-Small-Cell Lung Cancer In Vitro
  194. Rediscovering the Therapeutic Potential of Agarwood in the Management of Chronic Inflammatory Diseases
  195. Applications of extracellular vesicles as a drug-delivery system for chronic respiratory diseases
  196. Expanding the arsenal against pulmonary diseases using surface-functionalized polymeric micelles: breakthroughs and bottlenecks
  197. Attenuation of Cigarette-Smoke-Induced Oxidative Stress, Senescence, and Inflammation by Berberine-Loaded Liquid Crystalline Nanoparticles: In Vitro Study in 16HBE and RAW264.7 Cells
  198. ROR activation by Nobiletin enhances antitumor efficacy via suppression of IκB/NF-κB signaling in triple-negative breast cancer
  199. Dressing multifunctional nanoparticles with natural cell-derived membranes for superior chemotherapy
  200. Overcoming Multidrug Resistance of Antibiotics via Nanodelivery Systems
  201. Treating primary lymphoma of the brain in AIDS patients via multifunctional oral nanoparticulate systems
  202. Unravelling the molecular mechanisms underlying chronic respiratory diseases for the development of novel therapeutics via in vitro experimental models
  203. Berberine-loaded liquid crystalline nanoparticles inhibit non-small cell lung cancer proliferation and migration in vitro
  204. Concepts of advanced therapeutic delivery systems for the management of remodeling and inflammation in airway diseases
  205. Phytochemicals and their Nanoformulations Targeted for Pulmonary Diseases
  206. Epigenetic Therapy as a Potential Approach for Targeting Oxidative Stress–Induced Non-small-Cell Lung Cancer
  207. Role of autoimmunity in the pathogenesis of chronic obstructive pulmonary disease and pulmonary emphysema
  208. The science of matcha: Bioactive compounds, analytical techniques and biological properties
  209. Recent Advances in Chronotherapy Targeting Respiratory Diseases
  210. Applications of drug-delivery systems targeting inflammasomes in pulmonary diseases
  211. Bioactive Compounds from Zingiber montanum and Their Pharmacological Activities with Focus on Zerumbone
  212. Berberine-Loaded Liquid Crystalline Nanoparticles Inhibit Non-Small Cell Lung Cancer Proliferation and Migration in Vitro
  213. Nutraceuticals: unlocking newer paradigms in the mitigation of inflammatory lung diseases
  214. Berberine loaded liquid crystalline nanostructure inhibits cancer progression in adenocarcinomic human alveolar basal epithelial cells in vitro
  215. Interleukin-13: A pivotal target against influenza-induced exacerbation of chronic lung diseases
  216. Recent trends of NFκB decoy oligodeoxynucleotide-based nanotherapeutics in lung diseases
  217. Mitochondrial dysfunctions associated with chronic respiratory diseases and their targeted therapies: an update
  218. Versatility of liquid crystalline nanoparticles in inflammatory lung diseases
  219. Rutin loaded liquid crystalline nanoparticles inhibit non-small cell lung cancer proliferation and migration in vitro
  220. Current-status and applications of polysaccharides in drug delivery systems
  221. The FBXW7‐NOTCH interactome : A ubiquitin proteasomal system‐induced crosstalk modulating oncogenic transformation in human tissues
  222. Drug delivery advances in mitigating inflammation via matrix metalloproteinases in respiratory diseases
  223. Rutin-loaded liquid crystalline nanoparticles attenuate oxidative stress in bronchial epithelial cells: a PCR validation
  224. Targeting Cancer using Curcumin Encapsulated Vesicular Drug Delivery Systems
  225. Liensinine Prevents Vascular Inflammation by Attenuating Inflammatory Mediators and Modulating VSMC Function
  226. Genus Blepharis (Acanthaceae): A review of ethnomedicinally used species, and their phytochemistry and pharmacological activities
  227. Targeting respiratory diseases using miRNA inhibitor based nanotherapeutics: Current status and future perspectives
  228. Tea (Catechins Including (−)-Epigallocatechin-3-gallate) and Cancer
  229. Beyond the Obvious: Smoking and Respiratory Infection Implications on Alzheimer's Disease
  230. Advancing of Cellular Signaling Pathways in Respiratory Diseases Using Nanocarrier Based Drug Delivery Systems
  231. MicroRNAs as Biomarker for Breast Cancer
  232. Solid lipid nanoparticles containing anti-tubercular drugs attenuate the Mycobacterium marinum infection
  233. Anti‐inflammatory and anticancer activities of Naringenin‐loaded liquid crystalline nanoparticles in vitro
  234. Antiproliferative effects of boswellic acid-loaded chitosan nanoparticles on human lung cancer cell line A549
  235. Rutin loaded liquid crystalline nanoparticles inhibit lipopolysaccharide induced oxidative stress and apoptosis in bronchial epithelial cells in vitro
  236. Microparticles-Mediated Vascular Inflammation and its Amelioration by Antioxidant Activity of Baicalin
  237. Role of Lung Microbiome in Innate Immune Response Associated With Chronic Lung Diseases
  238. The GSK-3β-FBXL21 Axis Contributes to Circadian TCAP Degradation and Skeletal Muscle Function
  239. Smooth Muscle Cell Derived Microparticles Acts as Autocrine Activation of Smooth Muscle Cell Proliferation by Mitogen Associated Protein Kinase Upregulation
  240. Impact of bushfire smoke on respiratory health
  241. Plants derived therapeutic strategies targeting chronic respiratory diseases: Chemical and immunological perspective
  242. Molecular mechanisms of action of naringenin in chronic airway diseases
  243. Incipient need of targeting airway remodeling using advanced drug delivery in chronic respiratory diseases
  244. Eriobotrya japonica leaf extract attenuates airway inflammation in ovalbumin-induced mice model of asthma
  245. Cellular signalling pathways mediating the pathogenesis of chronic inflammatory respiratory diseases: an update
  246. Recent advances in experimental animal models of lung cancer
  247. Targeting neutrophils using novel drug delivery systems in chronic respiratory diseases
  248. Targeting lung cancer using advanced drug delivery systems
  249. Vascular Protection by Ethanol Extract of Morus alba Root Bark: Endothelium-Dependent Relaxation of Rat Aorta and Decrease of Smooth Muscle Cell Migration and Proliferation
  250. Phytochemical profile and pharmacological activity of Aegle marmelos Linn.
  251. Anticancer Activity ofPunica granatum(Pomegranate): A Review
  252. Phytochemical profile and biological activity of Juglans regia
  253. Cepharanthine inhibits in vitro VSMC proliferation and migration and vascular inflammatory responses mediated by RAW264.7
  254. Alkaloid rich fraction from Nelumbo nucifera targets VSMC proliferation and migration to suppress restenosis in balloon-injured rat carotid artery
  255. Chungtaejeon, a Korean fermented tea, prevents the risk of atherosclerosis in rats fed a high-fat atherogenic diet
  256. Circulating Endothelial Microparticles: A Key Hallmark of Atherosclerosis Progression
  257. Reactive Oxygen Species: A Key Hallmark of Cardiovascular Disease
  258. Antiatherogenic Effect ofCamellia japonicaFruit Extract in High Fat Diet-Fed Rats
  259. Phytochemical Profile and Biological Activity ofNelumbo nucifera
  260. Terminalia chebulaFructus Inhibits Migration and Proliferation of Vascular Smooth Muscle Cells and Production of Inflammatory Mediators in RAW 264.7
  261. Preventive Effect of Traditional Korean Formulations on Intimal Thickening of Rat Carotid Artery Injured by Balloon Catheter